Cargando…

Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome

Background. Primary Sjögren's syndrome (PSS) is a frequent systemic autoimmune disease. In this study, we aimed to explore the cognitive impairment and the correlations with brain MRI. Methods. Twenty-five patients (mean age 55 ± 11.8 years, 21 females) with PSS were prospectively selected and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanc, Frederic, Longato, Nadine, Jung, Barbara, Kleitz, Catherine, Di Bitonto, Laure, Cretin, Benjamin, Collongues, Nicolas, Sordet, Christelle, Fleury, Marie, Poindron, Vincent, Gottenberg, Jacques-Eric, Anne, Olivier, Lipsker, Dan, Martin, Thierry, Sibilia, Jean, de Seze, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793286/ https://www.ncbi.nlm.nih.gov/pubmed/24224097 http://dx.doi.org/10.1155/2013/501327

Ejemplares similares

White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica
por: Blanc, Frederic, et al.
Publicado: (2012)

No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2006)

Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
por: Chanson, Jean-Baptiste, et al.
Publicado: (2013)

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France
por: Felten, Renaud, et al.
Publicado: (2021)

Inflammatory-like presentation of CADASIL: a diagnostic challenge
por: Collongues, Nicolas, et al.
Publicado: (2012)

Chronic Bickerstaff’s encephalitis with cognitive impairment, a reality?
por: Renaud, Mathilde, et al.
Publicado: (2014)

Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies: An Observational Study
por: Bigaut, Kévin, et al.
Publicado: (2021)

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab
por: Felten, Renaud, et al.
Publicado: (2022)

Seasonal effect on fatigue, pain and dryness in primary Sjögren’s syndrome
por: Duret, Pierre-Marie, et al.
Publicado: (2020)

Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection
por: Bigaut, K., et al.
Publicado: (2021)

CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2007)

CTLA-4 polymorphism and primary Sjögren's syndrome: authors' response
por: Miceli-Richard, Corinne, et al.
Publicado: (2007)

Inclusion body myositis and Sjögren’s syndrome: the association works both ways
por: Giannini, Margherita, et al.
Publicado: (2022)

Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer’s Disease: A Longitudinal Study
por: Querry, Manon, et al.
Publicado: (2023)

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study
por: Bigaut, Kévin, et al.
Publicado: (2022)

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome?
por: Devauchelle-Pensec, Valérie, et al.
Publicado: (2015)

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome
por: Ittah, Marc, et al.
Publicado: (2006)

The contribution of epigenetics in Sjögren’s Syndrome
por: Konsta, Orsia D., et al.
Publicado: (2014)

ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?
por: Payet, J, et al.
Publicado: (2015)

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
por: Danion, François, et al.
Publicado: (2017)

Immunotherapies Targeting Amyloid and Tau Protein in Alzheimer’s Disease: Should We Move Away from Diseases and Focus on Biological Targets? A Systematic Review and Expert Opinion
por: Esquer, Arthur, et al.
Publicado: (2023)

Cognitive profile in prodromal dementia with Lewy bodies
por: Kemp, Jennifer, et al.
Publicado: (2017)

Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity
por: Scherlinger, Marc, et al.
Publicado: (2023)

Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjögren’s Syndrome. Data at Enrollment in the Prospective ASSESS Cohort
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2013)

The insula, a grey matter of tastes: a volumetric MRI study in dementia with Lewy bodies
por: Philippi, Nathalie, et al.
Publicado: (2020)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

Évolution de l’immunité cellulaire et humorale anti-SARS-CoV-2 après 3 doses de vaccins chez des patients traités par rituximab
por: Felten, R., et al.
Publicado: (2021)

Neural correlates of visual hallucinations in dementia with Lewy bodies
por: Heitz, Camille, et al.
Publicado: (2015)

Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial
por: Bodewes, Iris L A, et al.
Publicado: (2020)

CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One
por: Cretin, Benjamin, et al.
Publicado: (2021)

Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD)
por: Bigaut, Kévin, et al.
Publicado: (2019)

10 most important contemporary challenges in the management of SLE
por: Felten, Renaud, et al.
Publicado: (2019)

Higher risk of dementia in primary Sjogren's syndrome
por: Hou, Tsung‐Yun, et al.
Publicado: (2019)

Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren’s syndrome
por: Kawka, Lou, et al.
Publicado: (2023)

Disturbance of cytokine networks in Sjögren's syndrome
por: Youinou, Pierre, et al.
Publicado: (2011)

Insular atrophy at the prodromal stage of dementia with Lewy bodies: a VBM DARTEL study
por: Roquet, Daniel, et al.
Publicado: (2017)

Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort
por: Carvajal Alegria, Guillermo, et al.
Publicado: (2016)

Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
por: Felten, Renaud, et al.
Publicado: (2022)

Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome
por: Seror, Raphaele, et al.
Publicado: (2022)

Emotional experience is increased and emotion recognition decreased in multiple sclerosis
por: Pfaff, Line, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jla8kc7445a2map555nm7hts5i